Blue Laser Vaporization Effective for Benign Prostatic Hyperplasia
By Lori Solomon HealthDay Reporter
TUESDAY, April 8, 2025 -- Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a study published online March 4 in The Aging Male.
Zun-Jie Hu, from The Affiliated Taian City Central Hospital of Qingdao University in China, and colleagues assessed the impact of 450-nm blue laser vaporization on sexual function in 67 patients (median age, 65 years) undergoing BPH surgery and followed for three months.
The researchers found that blue laser vaporization significantly improved International Prostate Symptom Score, quality of life, and International Consultation on Incontinence Modular Questionnaire for Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) scores. Blue laser vaporization was also significantly associated with a reduction in postvoid residual volume. There were no significant changes seen in the International Index of Erectile Function 5 score, Male Sexual Health Questionnaire for Ejaculatory Dysfunction score, or ICIQ-MLUTS sex score, demonstrating preservation of sexual function after surgery.
"To determine the longevity of these effects, additional clinical data and extended follow-up periods are necessary," the authors write. "The findings present an effective surgical approach for safeguarding sexual function in BPH patients."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Aquablation Appears to Be Safe, Effective for Enlarged Prostates
TUESDAY, March 25, 2025 -- The Aquablation water-based surgical procedure is safe and effective for use with enlarged prostates compared with laser surgery, according to a study...
Acute Toxicity Following Prostate Radiotherapy Linked to Late Toxicity
WEDNESDAY, Feb. 12, 2025 -- For patients undergoing prostate radiotherapy, acute toxicity is associated with late toxicity and decrement in quality of life, according to a study...
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
THURSDAY, Feb. 6, 2025 -- For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.